Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) EPS (Basic) (2016 - 2026)

Collegium Pharmaceutical has reported EPS (Basic) over the past 10 years, most recently at $0.54 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 38.46% year-over-year to $0.54; the TTM value through Dec 2025 reached $2.0, down 6.54%, while the annual FY2025 figure was $1.98, 7.48% down from the prior year.
  • EPS (Basic) for Q4 2025 was $0.54 at Collegium Pharmaceutical, down from $1.0 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $2.06 in Q2 2021 and troughed at -$0.73 in Q4 2021.
  • A 5-year average of $0.34 and a median of $0.38 in 2023 define the central range for EPS (Basic).
  • Biggest five-year swings in EPS (Basic): tumbled 465.0% in 2021 and later surged 6000.0% in 2023.
  • Year by year, EPS (Basic) stood at -$0.73 in 2021, then skyrocketed by 71.23% to -$0.21 in 2022, then skyrocketed by 571.43% to $0.99 in 2023, then plummeted by 60.61% to $0.39 in 2024, then surged by 38.46% to $0.54 in 2025.
  • Business Quant data shows EPS (Basic) for COLL at $0.54 in Q4 2025, $1.0 in Q3 2025, and $0.38 in Q2 2025.